Continuing Education Activity
Atrioventricular canal defects comprise a spectrum of defects such as exclusive ventricular or atrial defects, septal defects, atrioventricular anomalies, and endocardial cushion defects. They are more commonly associated with chromosomal abnormalities, especially trisomy 21. There have also been incidences where we have seen these conditions in non-syndromic patients. Congenital heart diseases are one of the most important causes of infant mortality. AV canal defects comprise 3% to 5% of congenital heart disease (CHD). This article explains the incidence, the causes, and the pathophysiology of AV canal defects. It emphasizes on the early diagnosis and management of children with this condition by the interprofessional team, to prevent potential complications in the future.
- Review the conditions commonly associated with atrioventricular canal defects.
- Outline the typical presentation of a patient with atrioventricular canal defects
- Explain the complications that might arise in patients with uncorrected atrioventricular canal defects.
- Review the importance of improving care coordination among interprofessional team members to aid in early suspicion, diagnosis, and management of atrioventricular canal defects, to prevent cardiac failure and other morbidities in these patients.
Atrioventricular canal defects (AVCDs) comprise a spectrum of defects such as exclusive ventricular or atrial defects, septal defects, atrioventricular anomalies, and endocardial cushion defects. AVCDs are more commonly associated with chromosomal abnormalities, especially trisomy 21. There have also been incidences where there have been non-syndromic AVCDs.
Congenital heart diseases (CHD) are one of the most important causes of infant mortality. It has invariably led to adverse outcomes on the morbidity, lifestyle, and medical costs. The prevalence of ventricular and atrial septal defects is twice as high as the cyanotic heart diseases like tetralogy of Fallot (TOF) and transposition of great arteries (TGA). With the use of dynamic echocardiography, cardiologists have managed to diagnose early, asymptomatic, and even minute atrioventricular (AV) canal defects, which could be one of the reasons for the increased incidence of the CHDs over the past couple of decades. The incidence of CHDs in developing countries is yet to be established though it seems to be fairly similar to that of developed countries.
Most of the AV canal defects are almost always associated with a syndromic abnormality. The syndromes that carry an association with AV canal defects are CHARGE, Down, Ellis-van-Creveld, Ivemark, Kaufman McKusick, Ritscher-Schinzel, Smith-Lemli-Opitz, and 3p. Down’s syndrome has a very strong association with AV canal defects.
The incidence of AV canal defects obtained from several studies ranges from 0.24 to 0.31 per 1000 live births. It also comprises of 3% to 5% of the total CHDs. There is no gender preponderance, although some studies state that there is a slight female predilection (1:1.3), especially in cases associated with Down syndrome. This may, in turn, be seen as gender as an effect modifier in the association of Down syndrome with CHDs. Certain studies have proved that factors such as maternal gestational diabetes mellitus (GDM), pregestational diabetes mellitus, and obesity carry a significant association with the development of non-syndromic AV canal defects.
Forming a four-chambered heart involves coordination and organized fusion of several mesenchymal tissues. Mesenchymal tissue deposition on these endocardial cushions aids in the process of fusion, which in turn leads to the separation of the common AV canal. AV canal has superior and inferior endocardial cushions that fuse around 4 to 5 weeks of gestation. The failure of fusion of this endocardial cushion at various levels leads to septal defects ranging from partial to complete defects. The abnormal fusion of interatrial septum leads to communication in the inferior part of the septum called ostium primum defect.
The AV canal defects can primarily be classified into complete vs. partial defects based on the anatomical abnormalities.
- Complete: Complete failure of fusion of endocardial cushions leading to single AV valve, ostium primum septal defect, variable deficiency of IVS.
- Partial (intermediate/transitional): Incomplete fusion causing mitral valve abnormalities, usually a cleft in the anterior leaflet leading to MV regurgitation.
Further down, the complete AV canal defect may further be classified based on the AV valve morphology (Rastelli classification). The Rastelli classification is based on the insertion of the chordae and the morphology of the superior bridging leaflet.
- Type A: This is the most common type associated with Down syndrome. The superior bridging leaflets by means of chordal attachments are inserted on to the left ventricle.
- Type B: This is the least common. The superior bridging leaflets by means of chordal insertion is extended on to the body of the right ventricle.
- Type C: This is associated with tetralogy of Fallot (TOF), transposition of great arteries (TGA), etc. There are free-floating superior bridging leaflets with no chordal insertions.
History and Physical
In patients with complete AV canal defect, mostly symptoms of pulmonary over circulation develop before the age of 6 months, and the severity of symptoms depends on the size and the type of the defects.
Tachypnea, difficulty to gain weight are the first signs noticeable in patients with AV canal defects. The occurrence and severity of symptoms depend on the degree of AV valve regurgitation and other associated CHD, which can contribute to the early development of congestive heart failure (CHF).
In patients with partial AV canal defect, symptoms might not be detected in the first few years of life and might manifest later in childhood. Of note, ostium primum atrial septal defect (ASD) seen in AV canal defects presents earlier than ostium secundum ASD. The most common presentation is for evaluation of a murmur, heard secondary to increased flow across the pulmonary valve, which is heard best at the upper left sternal border.
Symptoms of CHF - increased work of breathing, sweating while feeding, poor feeding, lethargy, or increased sleepiness.
Signs of CHF - tachypnea, tachycardia, failure to thrive (fall across two major centiles on the growth chart), wheezing or rales on lung auscultation, S3 gallop rhythm, apical displacement of the apical impulse, hepatomegaly, increased jugular venous pressure (JVP).
A careful and complete cardiac exam should be done to look for:
- Wide and fixed split S2 - heard due to left to right shunting across the ASD causing increased blood flow in the right side of the hear irrespective of the phase of respiration
- S3 - due to increased flow of blood splashing across the left ventricular walls which are still compliant
- Additional murmurs:
- Holosystolic murmur secondary to left AV valve regurgitation is heard best at the apex
- Mid diastolic murmur - If the shunt is large or if there is significant AV valve regurgitation.
Signs on General Physical Exam
Dysmorphic features: Flat facies, upslanting palpebral fissures, single palmar crease, saddle toe are commonly seen in children with Down syndrome, and should be evaluated for especially in a patient whose karyotype is not known (40% to 45% of patients with Down syndrome have AV canal defect).
A survey to look for other congenital anomalies including cleft lip, cleft palate, musculoskeletal abnormalities should also be done.
Routine antenatal screening with fetal echocardiography has been able to aid in the early diagnosis of septal defects. The cases that were diagnosed during the antenatal period generally carry a poor prognosis. When a defect is suspected in such screening, they are usually referred for a much more detailed fetal echocardiography, which can accurately depict the type of defect, associated valve morphology, presence of a shunt, and blood flow parameters. The radiological diagnosis during the postnatal period is usually performed when there are CHF signs, symptoms in a newborn, or if diagnosed (or suspected) during antenatal screening. With the recent advances in Doppler echocardiography, the diagnosis of AV canal defects is no longer dependent on cardiac catheterization. Routine cardiac catheterization is done prior to surgical correction to delineate the anatomy.
In partial defect, chest X-ray shows right heart enlargement with increased pulmonary vasculature. While intermediate and complete forms show more of the diffuse enlargement of all chambers, although left atrial involvement is unusual and left ventricular enlargement is not very obvious due to the masking by the enlarged right ventricles.
The characteristic ECG finding in AV canal defects is the presence of a superior axis directed more towards the left. The next most common finding is the presence of rsR’ or rR’ in the right precordial leads caused due to the volume/pressure overload. The other findings include prolongation of the PR interval and right ventricular enlargement.
Treatment / Management
The definitive management of complete atrioventricular canal defect (CAVCD) is the surgical correction of the defect as early as possible. However, overall management can be divided into three parts. Initial medical management, definitive surgical correction, and long-term follow-up care.
The timing of correction is preferably before 6 months of age, as the risk of developing pulmonary vascular disease is directly related to the duration of the disease. The medical management is generally directed towards improving the myocardial function by means of reducing the preload and afterload using diuretics and angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB). To improve contractility, inotropic agents such as digoxin is used. Surgical management of CAVCD is dependent on various factors such as the type of defect, valve morphology, associated valvular and conduction abnormalities, the presence of shunt, and other vascular anomalies. The intra-operative mortality rate is 3%, and the 10-year survival rate is more than 90%.
1. Balanced lesion
Primary complete repair
- Modified single-patch
2. Unbalanced lesion
Palliative intervention: Single ventricle palliation (usually done for HLHS and tricuspid atresia)
Partial and Intermediate AVCD
Primary surgical repair
- Patch closure
- Mitral valvuloplasty
Long-term Follow-up Care
Annual cardiologist evaluation is recommended to check for and prevent complications in uncorrected individuals and due to surgery. Children with AVCD are at risk for neurological impairment; hence routine screening for neurological and developmental disorders is advised. The other general measures that have to be taken care of are infective endocarditis prophylaxis, risk assessment during pregnancy.
The differential diagnosis mainly consists of large ventricular septal defect, ASD, surgery for VSD due to the CHF symptoms that are common with AVCD. Though ECG and chest x-ray may share some common features, echocardiography can be efficiently used for an accurate diagnosis.
The mortality rate of patients treated with for atrioventricular canal defects is estimated to be 3%. 90% of treated patients have a 10-year survival rate. The reoperation rate is found to be 10% to 20%. The most common cause of reoperation, that occurs in 5-10% of patients is the worsening of mitral regurgitation.
The patients will eventually start to develop left to right shunt irrespective of the type of defect, although the magnitude of the shunting depends on the type of defect. In complete AV canal defects, blood from the left to right flow through interatrial, interventricular, and AV valves, while in a partial defect, blood flows through the ostium primum. These individuals develop heart failure symptoms even before the age of one if it is not corrected. Due to the increased flow to the right heart, the pulmonary vasculature develops pulmonary hypertension. There is a slight symptomatic improvement during the initial phase of this change, which is one of the poor prognostic factors as it may lead to Eisenmenger syndrome. There is a significant regurgitation of blood in the heart chambers due to incompetent AV valves. Most of the regurgitation happens from ventricles to the atrium of the same side, although some occur from LV to RA through the cleft in the anterior mitral leaflet. This can lead to atrial dilatation or ventricular hypertrophy, depending on the defect, which can accelerate the development of congestive heart failure in children.
Deterrence and Patient Education
How is the atrioventricular canal defect diagnosed?
Usually by a pediatric cardiologist who looks for symptoms of heart failure, or on examination hears a murmur. To support his suspicion of underlying heart disease, there might be additional tests done. They can include
Chest X-ray. X-rays are used to take a picture of the heart and lungs.
Electrocardiogram (ECG). The test records the electrical activity of the heart.
Echocardiogram (echo). Sound waves (ultrasound) are used to create a picture of the heart and look for structural defects.
Pulse oximetry. The test looks at how much oxygen is in the blood.
Cardiac catheterization. The test measures blood pressure and oxygen inside the heart. It also lets the doctor look at the inside of the heart. The test is done with a long thin tube (catheter) that is put in through a blood vessel in the groin or other area and moved to the heart.
Cardiac MRI. This test gives 3-D images of the heart. It can show any defects.
How is the atrioventricular canal defect treated?
They are usually treated early in infancy with heart surgery (the first 6 months of life). Sometimes, medications can help control the symptoms until the surgery is scheduled. They can include:
Water pills (diuretics), which help rid the body of excess water. This reduces fluid in the lungs and may improve breathing.
Digoxin, which helps the heart pump blood with more force. This improves how the heart works.
ACE inhibitors, which make blood vessels relax and allow blood to flow more easily from the heart.
Enhancing Healthcare Team Outcomes
The management of atrioventricular canal defects is challenging and complex. To derive good outcomes, there should be good communication between the cardiac surgeons and the primary cardiology team taking care of the patient. It is important to define the anatomy and the surgical approach prior to taking the patient to surgery. In some cases, a smaller ventricle or a straddling valve may preclude definitive biventricular repair - thus, the importance of having a cardiac conference with a team of cardiologists and cardiovascular surgeons helps in discussing the management (both preoperative and postoperative). As with any other complex procedure, the preoperative workup must be thorough, and the patient should be seen by a cardiologist to optimize cardiac function with the help of anti-failure medications as needed. Because of the potential risk of complications, if surgery is done earlier in life, it is important to have a nutritionist to help make sure that adequate weight gain takes place prior to surgery.
In the postoperative period, the role of the nurse and pharmacist is critical. The nurses will assist the team by monitoring the patient for pain, sternotomy site infection, chest tube output management, and a variety of common postoperative complications such as atelectasis, deep vein thrombosis, postpericardiotomy syndrome, and pain. The pharmacist may be involved in parenteral nutrition if needed until the patient is able to take feeds enterally. The need for meticulous planning and discussion with other professionals involved in the management of the patient is highly recommended to lower the morbidity and improve outcomes.